JiLLiON Therapeutics Inc.
Biotechnology company · Brooklyn, New York, United States
JiLLiON Therapeutics Inc. is a biotechnology company headquartered in Brooklyn, New York, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.7 million in total, most recently in 2025.
JiLLiON Therapeutics at a glance
What does JiLLiON Therapeutics do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $1.7 million in total (2024 to 2025). NIH funding came from the National Institute on Drug Abuse, National Institute on Aging.
Frequently asked questions about JiLLiON Therapeutics
Where is JiLLiON Therapeutics headquartered?
JiLLiON Therapeutics Inc. is headquartered in Brooklyn, New York, United States.
What does JiLLiON Therapeutics do?
JiLLiON Therapeutics Inc. is a biotechnology company.
Similar companies
- Phoenix Nest Inc.Brooklyn, New York, United States
- Chemitope Glycopeptide Inc.Brooklyn, New York, United States
- Accutar Biotechnology Inc.Brooklyn, New York, United States
- Loki Therapeutics, IncBrooklyn, New York, United States
- Concarlo Holdings, LLCBrooklyn, New York, United States
- Lucerna IncBrooklyn, New York, United States
- Xylyx Bio, Inc.Brooklyn, New York, United States
- Fesariustherapeutics IncBrooklyn, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences